Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Turn Biotechnologies Introduces its Dermatology Platform to the European Aesthetic Community at AMWC 2023-03-30 20:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization 2023-03-30 18:54
DxVx Co., Ltd.'s affiliated company, Oxford Vacmedix (OVM) successfully completed Phase 1a in clinical trial of novel cancer vaccine OVM-200 2023-03-30 17:39
Great Place To Work unveils Best Workplaces in the Inaugural Singapore Healthcare and Biopharma List 2023 2023-03-30 12:00
ImmVira's oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA's approval for Clinical Trial in China 2023-03-30 08:00
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 406 Patients 2023-03-30 08:00
Athos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063 2023-03-30 03:32
bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases 2023-03-29 22:00
HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth 2023-03-29 19:00
BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia 2023-03-29 16:00
Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public 2023-03-29 14:06
Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer 2023-03-29 14:00
Antengene Announces First Patient Dosed with Claudin 18.2 Antibody-Drug Conjugate ATG-022 for the Treatment of Patients with Advanced or Metastatic Solid Tumors in Australia 2023-03-29 08:30
Innovent Announces 2022 Annual Results and Business Updates 2023-03-29 08:00
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China 2023-03-28 21:41
Antengene Announces Results for Full Year 2022 with Updates Highlighting a Sales Revenue Reaching 5.6 Times Year-Over-Year and Accelerated Global Innovation 2023-03-28 21:40
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award 2023-03-28 20:00
Sirnaomics Announces 2022 Annual Results 2023-03-28 19:26
Seegene declares to share Syndromic PCR technologies to prevent future pandemics 2023-03-28 19:00
Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours 2023-03-28 19:00
1 117 118 119 120 121 416